Delivery Order SPE2DR25D1202-SPE2DR26F73ES
Award Date 12/17/25
Potential Completion Date 1/9/26
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $5,878.86 for the supply of Zoladex 10.8 mg implant syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order is scheduled for completion by December 29, 2025, and represents a continuation of AmerisourceBergen's extensive role as a critical pharmaceutical supplier to the federal government's military and healthcare systems. The work will be...
- The Defense Logistics Agency awarded a delivery order valued at $17,636.58 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This competitively awarded, firm fixed-price contract was executed on December 3, 2025, with an ultimate completion date of December 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zoladex 3.6 mg implant syringes, with a ceiling value of $1,395.16. This is a firm fixed price delivery order with an ultimate completion date of December 31, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through...
- The Defense Logistics Agency awarded a $5,578.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Zoladex 10.8 mg implant syringes, with completion scheduled for October 14, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,297.50 on August 12, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a completion date of September 3, 2025. This non-set-aside, competitively awarded contract carries firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $11,157.00 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes, with an ultimate completion date of October 8, 2025. This non-competitive, firm fixed-price delivery order was issued on September 17, 2025, with performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes valued at $5,578.50 with a firm fixed price contract type. The award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025. This is a non-set-aside competitive award, with performance to occur at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $23,515.44 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This firm fixed price contract was competitively awarded without set-aside designation and carries an ultimate completion date of December 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on December 18, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a contract ceiling value of $14,697.15. This firm fixed-price delivery order, which is expected to be completed by January 12, 2026, was competitively awarded with no set-aside designation. The pharmaceutical products will be distributed from the company's corporate office location in Conshohocken, Pennsylvania, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a ceiling value of $9,798.10 and a firm fixed price structure. This non-set-aside contract is set to complete by December 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...